| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |